Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of ...
Modeling the cost-effectiveness of granulocyte colony-stimulating factor use in early-stage breast cancer. A total of 238 women with breast cancer before age 50 or ovarian cancer at any age and at ...
The study showed that oxidative stress, which is considered to contribute to cancer development, actually suppressed cancer in rats with BRCA2 gene mutations. Oxidative stress is considered to ...
Zoe Wilson thought she may be at risk. It wasn’t just a vague gut feeling: the risk was demonstrable and clear, running ...
Hundreds of people filled the Hollywood Broadwalk on Saturday for the Waves of Hope 5K, an annual walk and run raising ...
In this study, researchers aimed to determine whether younger BRCA1/2 carriers who undergo oophorectomy can receive menopausal hormone therapy without increasing their risk of breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback